主要股东
注：以下部分股东代表特定权益共同体，直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | David Grayzel | 否 | 257.18万 | 9.60% | 新增 | 新增 | -- |
| 2 | F-Prime Capital Partners Healthcare Fund IV LP and affiliates | 是 | 190.77万 | 7.20% | 新增 | 新增 | -- |
| 3 | Entities affiliated with Bain Capital Life Sciences Investors, LLC | 是 | 151.29万 | 5.70% | 新增 | 新增 | -- |
| 4 | Entities affiliated with Deerfield Management Company, L.P. | 是 | 151.29万 | 5.70% | 新增 | 新增 | -- |
| 5 | Daniel Curran | 否 | 147.51万 | 5.50% | 新增 | 新增 | -- |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2025-06-16 | Russo Rene |
|
28.12 | 0.68 | 是 | PRESIDENT AND CEO |
| 2025-06-16 | Shannon James Samuel |
|
4.50 | 0.69 | 是 | -- |
| 2025-06-16 | Shannon James Samuel |
|
7.00 | 0.69 | 是 | -- |
| 2025-01-01 | Russo Rene |
|
24.49 | -- | 是 | PRESIDENT AND CEO |
| 2025-01-01 | Brennan Kevin M. |
|
0.50 | -- | 是 | SVP, FINANCE AND ACCOUNTING |
| 2025-01-01 | Brennan Kevin M. |
|
0.32 | 0.98 | 是 | SVP, FINANCE AND ACCOUNTING |
| 2025-01-01 | Frankenfield Christopher James |
|
1.94 | -- | 是 | Chief Financial Officer |
| 2025-01-01 | Frankenfield Christopher James |
|
1.24 | 0.98 | 是 | Chief Financial Officer |
| 2025-01-01 | Luptakova Katarina |
|
1.66 | -- | 是 | CHIEF MEDICAL OFFICER |
| 2024-12-18 | GILEAD SCIENCES, INC. |
|
910.55 | 1.04 | 是 | -- |
| 2024-04-02 | GILEAD SCIENCES, INC. |
|
734.55 | 0.76 | 是 | -- |
| 2024-02-08 | Atlas Venture Fund XI, L.P. |
|
201.96 | 0.64 | 是 | -- |
| 2024-01-11 | Atlas Venture Fund XI, L.P. |
|
202.03 | 0.83 | 是 | -- |
| 2024-01-11 | Atlas Venture Fund XI, L.P. |
|
202.18 | 0.87 | 是 | -- |